A phase 3, placebo controlled, doubleblind,randomized, clinical study to determine efficacy, safety and tolerability of pulsed,inhaled nitric oxid (iNO) versus placebo in symptomatic subjects with

  • Brown, Martin (Primary Chief Investigator)
  • Butala, Radhika (Research Assistant)

Project: Research

Project Details

StatusFinished
Effective start/end date11/11/16 → 30/09/18